Viewing Study NCT05437250


Ignite Creation Date: 2025-12-24 @ 5:20 PM
Ignite Modification Date: 2025-12-25 @ 2:56 PM
Study NCT ID: NCT05437250
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-03
First Post: 2022-06-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: National Acalabrutinib Observational Study
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Lymphocytic Leukemia View
Keywords: